New Delhi: Government of India is doing everything possible to increase availability of Liposomal Amphotericin B injections to deal with Mucormycosis. To augment production, Government of India has given licenses to 5 more companies which can make this drug.
PM had instructed officials to get this drug from anywhere it is available in the world.
After these instructions, Indian missions across the world have been involved in securing supplies of this drug. As a result of proactive efforts, the following has been achieved with help of Gilead Sciences in USA.
Gilead Sciences is working on expediting the supply of AmBisome to India through Mylan.
More than 121,000 vials have so far reached India. Another 85,000 vials are on the way.
The company will supply 1 million doses of AmBisome to India through Mylan.
The company is also withdrawing the stocks available in other countries, which would be supplied to India.
